Skyward Specialty Insurance Group Inc. Common Stock (SKWD)
Fast GrowerFairStock Score: 83/100 — HIGH CONVICTION
Key Financials
| Current Price | $46.01 |
| Market Cap | $2.1B |
| P/E Ratio | 11.09 |
| ROE | 17.12% |
| Dividend Yield | —% |
| Sector | Financial Services |
Strengths
- Solid return on equity of 18.9% above cost of capital
- Conservative balance sheet with debt-to-equity of just 0.12, providing financial flexibility
- Revenue growth of 26.7% demonstrates strong top-line momentum
- FairStock composite score of 83/100 places it in the top tier across value, quality, and momentum factors
Concerns
- Altman Z-Score of 0.5 places it in the financial distress zone—elevated bankruptcy risk
AI Analysis
Skyward Specialty Insurance Group Inc. Common Stock is a small-cap financial services company valued at $2.1 billion. The business generates $1.4 billion in annual revenue with a 3.1% net margin. From a quality standpoint, Skyward shows distressed Altman Z-Score of 0.5 warrants caution and adequate 19% ROE. On valuation, the stock is attractively valued at 11.3x earnings, with a modest 3% margin of safety vs Graham Number. Growth dynamics show revenue growing at 26.7% and profit growth of 200.1%. Our composite FairStock Score of 83/100 reflects strong fundamentals overall. This combination of reasonable valuation, solid returns, and conservative leverage makes it worth a closer look for value-oriented portfolios.
Bull Case
Skyward's 27% revenue growth trajectory could accelerate as it captures additional market share in the financial services sector. Operational leverage in the business model means incremental revenue growth could disproportionately boost bottom-line profitability.
Bear Case
Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the financial services space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.
Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer